Quilter Plc Has $57.62 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

Quilter Plc increased its position in shares of Zoetis Inc. (NYSE:ZTS) by 17.9% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 353,674 shares of the company’s stock after purchasing an additional 53,596 shares during the quarter. Zoetis makes up approximately 1.1% of Quilter Plc’s holdings, making the stock its 29th biggest holding. Quilter Plc owned approximately 0.08% of Zoetis worth $57,624,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ZTS. Darwin Wealth Management LLC acquired a new stake in Zoetis in the 3rd quarter valued at about $31,000. First Personal Financial Services acquired a new stake in Zoetis in the 3rd quarter valued at about $33,000. Capital Performance Advisors LLP bought a new position in shares of Zoetis in the 3rd quarter valued at about $33,000. Dunhill Financial LLC boosted its stake in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares during the last quarter. Finally, Fortitude Family Office LLC boosted its stake in shares of Zoetis by 1,387.5% in the 3rd quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after purchasing an additional 222 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Zoetis Trading Down 1.6 %

Shares of Zoetis stock opened at $171.37 on Monday. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The firm has a 50-day moving average of $169.26 and a 200-day moving average of $179.22. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.27 and a current ratio of 3.69. The stock has a market cap of $77.32 billion, a PE ratio of 32.21, a PEG ratio of 2.77 and a beta of 0.90.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be given a dividend of $0.50 per share. The ex-dividend date is Monday, April 21st. This represents a $2.00 annualized dividend and a yield of 1.17%. Zoetis’s dividend payout ratio is 37.59%.

Analyst Upgrades and Downgrades

ZTS has been the topic of several recent research reports. Stifel Nicolaus reduced their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Leerink Partners assumed coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price objective on the stock. UBS Group began coverage on shares of Zoetis in a research note on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective on the stock. Morgan Stanley dropped their target price on shares of Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a report on Wednesday, January 29th. Finally, Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Zoetis has a consensus rating of “Buy” and an average price target of $215.00.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.